OVASUITE
LIVE

Serial Number

97584013

Owner

ASPIRA WOMEN'S HEALTH INC.

Attorney

Melissa Hunter-Ensor

Filing Date

Sep 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

OVASUITE Trademark

Serial Number: 97584013

OVASUITE is a trademark filed by ASPIRA WOMEN'S HEALTH INC. on September 8, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

ASPIRA WOMEN'S HEALTH INC. (83 trademarks)

12117 BEE CAVES ROAD
AUSTIN, TX 78738

Entity Type: 03

Trademark Details

Filing Date

September 8, 2022

Registration Date

Not Registered

Goods & Services

Providing reagent sample testing and diagnostic services for others for scientific research purposes; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; providing medical and scientific research information; providing medical and scientific research information in the field of cancer detection and clinical trials; providing medical and scientific research information in the field of ovarian cancer detection and clinical trials; providing medical and scientific research information in the field of breast cancer detection and clinical trials; providing medical and scientific research services in the field of biomarker testing and cancer screening; medical and scientific research services in the field of cancer treatment and diagnosis; medical and scientific research services in the field of ovarian cancer treatment and diagnosis; medical and scientific research services in the field of breast treatment and diagnosis; medical and scientific research services in the field of cancer treatment and diagnosis; medical and scientific research services in the fields of women's health, genetics, gynecology and cancer; scientific research consulting in the field of genetics; product development in the fields of women's health, genetics, gynecology, diagnostics and cancer; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; consulting services in the fields of laboratory testing and diagnostics; providing a web hosting platform for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; platform as a service (PAAS) featuring computer software platforms for diagnostic testing in the field of women's health; software as a service (SAAS) services featuring software for diagnostic testing; software as a service (SAAS) services featuring software for cancer diagnostic testing; software as a service (SAAS) services featuring software for genetic testing; software as a service (SAAS) services featuring software using artificial intelligence for medical diagnostic testing; providing on-line non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; providing temporary use of on-line non-downloadable software and applications using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing; providing a website featuring non-downloadable software using artificial intelligence for medical diagnostic testing, cancer diagnostic testing, gynecological diagnostic testing, and genetic testing

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 25, 2026 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 24, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 23, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 22, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 2, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 19, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 19, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jan 19, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 19, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 19, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 24, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 24, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 24, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 22, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2022 NWOS
NEW APPLICATION ENTERED
Sep 12, 2022 NWAP